Table of Content

1 Neurological Drugs Market Overview
1.1 Neurological Drugs Product Overview
1.2 Neurological Drugs Market Segment by Type
1.2.1 Non-prescription drugs
1.2.2 Prescription
1.3 Global Neurological Drugs Market Size by Type
1.3.1 Global Neurological Drugs Market Size Overview by Type (2018-2034)
1.3.2 Global Neurological Drugs Historic Market Size Review by Type (2018-2023)
1.3.3 Global Neurological Drugs Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Neurological Drugs Sales Breakdown by Type (2018-2023)
1.4.2 Europe Neurological Drugs Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Neurological Drugs Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Neurological Drugs Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Neurological Drugs Sales Breakdown by Type (2018-2023)
2 Global Neurological Drugs Market Competition by Company
2.1 Global Top Players by Neurological Drugs Sales (2018-2023)
2.2 Global Top Players by Neurological Drugs Revenue (2018-2023)
2.3 Global Top Players by Neurological Drugs Price (2018-2023)
2.4 Global Top Manufacturers Neurological Drugs Manufacturing Base Distribution, Sales Area, Product Type
2.5 Neurological Drugs Market Competitive Situation and Trends
2.5.1 Neurological Drugs Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Neurological Drugs Sales and Revenue in 2024
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Drugs as of 2024)
2.7 Date of Key Manufacturers Enter into Neurological Drugs Market
2.8 Key Manufacturers Neurological Drugs Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Neurological Drugs Status and Outlook by Region
3.1 Global Neurological Drugs Market Size and CAGR by Region: 2018 VS 2024 VS 2034
3.2 Global Neurological Drugs Historic Market Size by Region
3.2.1 Global Neurological Drugs Sales in Volume by Region (2018-2023)
3.2.2 Global Neurological Drugs Sales in Value by Region (2018-2023)
3.2.3 Global Neurological Drugs Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Neurological Drugs Forecasted Market Size by Region
3.3.1 Global Neurological Drugs Sales in Volume by Region (2024-2034)
3.3.2 Global Neurological Drugs Sales in Value by Region (2024-2034)
3.3.3 Global Neurological Drugs Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Neurological Drugs by Application
4.1 Neurological Drugs Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.2 Global Neurological Drugs Market Size by Application
4.2.1 Global Neurological Drugs Market Size Overview by Application (2018-2034)
4.2.2 Global Neurological Drugs Historic Market Size Review by Application (2018-2023)
4.2.3 Global Neurological Drugs Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Neurological Drugs Sales Breakdown by Application (2018-2023)
4.3.2 Europe Neurological Drugs Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Neurological Drugs Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Neurological Drugs Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Neurological Drugs Sales Breakdown by Application (2018-2023)
5 North America Neurological Drugs by Country
5.1 North America Neurological Drugs Historic Market Size by Country
5.1.1 North America Neurological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2024 VS 2034
5.1.2 North America Neurological Drugs Sales in Volume by Country (2018-2023)
5.1.3 North America Neurological Drugs Sales in Value by Country (2018-2023)
5.2 North America Neurological Drugs Forecasted Market Size by Country
5.2.1 North America Neurological Drugs Sales in Volume by Country (2024-2034)
5.2.2 North America Neurological Drugs Sales in Value by Country (2024-2034)
6 Europe Neurological Drugs by Country
6.1 Europe Neurological Drugs Historic Market Size by Country
6.1.1 Europe Neurological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2024 VS 2034
6.1.2 Europe Neurological Drugs Sales in Volume by Country (2018-2023)
6.1.3 Europe Neurological Drugs Sales in Value by Country (2018-2023)
6.2 Europe Neurological Drugs Forecasted Market Size by Country
6.2.1 Europe Neurological Drugs Sales in Volume by Country (2024-2034)
6.2.2 Europe Neurological Drugs Sales in Value by Country (2024-2034)
7 Asia-Pacific Neurological Drugs by Region
7.1 Asia-Pacific Neurological Drugs Historic Market Size by Region
7.1.1 Asia-Pacific Neurological Drugs Market Size Growth Rate (CAGR) by Region: 2018 VS 2024 VS 2034
7.1.2 Asia-Pacific Neurological Drugs Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Neurological Drugs Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Neurological Drugs Forecasted Market Size by Region
7.2.1 Asia-Pacific Neurological Drugs Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Neurological Drugs Sales in Value by Region (2024-2034)
8 Latin America Neurological Drugs by Country
8.1 Latin America Neurological Drugs Historic Market Size by Country
8.1.1 Latin America Neurological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2024 VS 2034
8.1.2 Latin America Neurological Drugs Sales in Volume by Country (2018-2023)
8.1.3 Latin America Neurological Drugs Sales in Value by Country (2018-2023)
8.2 Latin America Neurological Drugs Forecasted Market Size by Country
8.2.1 Latin America Neurological Drugs Sales in Volume by Country (2024-2034)
8.2.2 Latin America Neurological Drugs Sales in Value by Country (2024-2034)
9 Middle East and Africa Neurological Drugs by Country
9.1 Middle East and Africa Neurological Drugs Historic Market Size by Country
9.1.1 Middle East and Africa Neurological Drugs Market Size Growth Rate (CAGR) by Country: 2018 VS 2024 VS 2034
9.1.2 Middle East and Africa Neurological Drugs Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Neurological Drugs Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Neurological Drugs Forecasted Market Size by Country
9.2.1 Middle East and Africa Neurological Drugs Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Neurological Drugs Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Pfizer
10.1.1 Pfizer Company Information
10.1.2 Pfizer Introduction and Business Overview
10.1.3 Pfizer Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Pfizer Neurological Drugs Products Offered
10.1.5 Pfizer Recent Development
10.2 Ely Lilly
10.2.1 Ely Lilly Company Information
10.2.2 Ely Lilly Introduction and Business Overview
10.2.3 Ely Lilly Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Ely Lilly Neurological Drugs Products Offered
10.2.5 Ely Lilly Recent Development
10.3 Actavis
10.3.1 Actavis Company Information
10.3.2 Actavis Introduction and Business Overview
10.3.3 Actavis Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Actavis Neurological Drugs Products Offered
10.3.5 Actavis Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Neurological Drugs Products Offered
10.4.5 Mylan Recent Development
10.5 Randox
10.5.1 Randox Company Information
10.5.2 Randox Introduction and Business Overview
10.5.3 Randox Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Randox Neurological Drugs Products Offered
10.5.5 Randox Recent Development
10.6 Intellipharmaceutics
10.6.1 Intellipharmaceutics Company Information
10.6.2 Intellipharmaceutics Introduction and Business Overview
10.6.3 Intellipharmaceutics Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Intellipharmaceutics Neurological Drugs Products Offered
10.6.5 Intellipharmaceutics Recent Development
10.7 Astrazeneca
10.7.1 Astrazeneca Company Information
10.7.2 Astrazeneca Introduction and Business Overview
10.7.3 Astrazeneca Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Astrazeneca Neurological Drugs Products Offered
10.7.5 Astrazeneca Recent Development
10.8 Lundbeck
10.8.1 Lundbeck Company Information
10.8.2 Lundbeck Introduction and Business Overview
10.8.3 Lundbeck Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Lundbeck Neurological Drugs Products Offered
10.8.5 Lundbeck Recent Development
10.9 Allergan
10.9.1 Allergan Company Information
10.9.2 Allergan Introduction and Business Overview
10.9.3 Allergan Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Allergan Neurological Drugs Products Offered
10.9.5 Allergan Recent Development
10.10 GSK
10.10.1 GSK Company Information
10.10.2 GSK Introduction and Business Overview
10.10.3 GSK Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 GSK Neurological Drugs Products Offered
10.10.5 GSK Recent Development
10.11 Otsuka Pharmaceutical
10.11.1 Otsuka Pharmaceutical Company Information
10.11.2 Otsuka Pharmaceutical Introduction and Business Overview
10.11.3 Otsuka Pharmaceutical Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Otsuka Pharmaceutical Neurological Drugs Products Offered
10.11.5 Otsuka Pharmaceutical Recent Development
10.12 Takeda
10.12.1 Takeda Company Information
10.12.2 Takeda Introduction and Business Overview
10.12.3 Takeda Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Takeda Neurological Drugs Products Offered
10.12.5 Takeda Recent Development
10.13 NHU Group
10.13.1 NHU Group Company Information
10.13.2 NHU Group Introduction and Business Overview
10.13.3 NHU Group Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 NHU Group Neurological Drugs Products Offered
10.13.5 NHU Group Recent Development
10.14 Shionogi
10.14.1 Shionogi Company Information
10.14.2 Shionogi Introduction and Business Overview
10.14.3 Shionogi Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Shionogi Neurological Drugs Products Offered
10.14.5 Shionogi Recent Development
10.15 APOTEX
10.15.1 APOTEX Company Information
10.15.2 APOTEX Introduction and Business Overview
10.15.3 APOTEX Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 APOTEX Neurological Drugs Products Offered
10.15.5 APOTEX Recent Development
10.16 North China Pharmaceutical
10.16.1 North China Pharmaceutical Company Information
10.16.2 North China Pharmaceutical Introduction and Business Overview
10.16.3 North China Pharmaceutical Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 North China Pharmaceutical Neurological Drugs Products Offered
10.16.5 North China Pharmaceutical Recent Development
10.17 Harbin Pharmaceutical Co., Ltd.
10.17.1 Harbin Pharmaceutical Co., Ltd. Company Information
10.17.2 Harbin Pharmaceutical Co., Ltd. Introduction and Business Overview
10.17.3 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 Harbin Pharmaceutical Co., Ltd. Neurological Drugs Products Offered
10.17.5 Harbin Pharmaceutical Co., Ltd. Recent Development
10.18 Lukang Pharmaceutical
10.18.1 Lukang Pharmaceutical Company Information
10.18.2 Lukang Pharmaceutical Introduction and Business Overview
10.18.3 Lukang Pharmaceutical Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.18.4 Lukang Pharmaceutical Neurological Drugs Products Offered
10.18.5 Lukang Pharmaceutical Recent Development
10.19 Kelun Pharmaceutical
10.19.1 Kelun Pharmaceutical Company Information
10.19.2 Kelun Pharmaceutical Introduction and Business Overview
10.19.3 Kelun Pharmaceutical Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.19.4 Kelun Pharmaceutical Neurological Drugs Products Offered
10.19.5 Kelun Pharmaceutical Recent Development
10.20 Kehua Biology
10.20.1 Kehua Biology Company Information
10.20.2 Kehua Biology Introduction and Business Overview
10.20.3 Kehua Biology Neurological Drugs Sales, Revenue and Gross Margin (2018-2023)
10.20.4 Kehua Biology Neurological Drugs Products Offered
10.20.5 Kehua Biology Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Neurological Drugs Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Neurological Drugs Industrial Chain Analysis
11.4 Neurological Drugs Market Dynamics
11.4.1 Neurological Drugs Industry Trends
11.4.2 Neurological Drugs Market Drivers
11.4.3 Neurological Drugs Market Challenges
11.4.4 Neurological Drugs Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Neurological Drugs Distributors
12.3 Neurological Drugs Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Non-prescription drugs
Table 2. Major Company of Prescription
Table 3. Global Neurological Drugs Sales by Type 2018 VS 2024 VS 2034 (US$ Million)
Table 4. Global Neurological Drugs Sales by Type (2018-2023) & (K Units)
Table 5. Global Neurological Drugs Sales Market Share in Volume by Type (2018-2023)
Table 6. Global Neurological Drugs Sales by Type (2018-2023) & (US& Million)
Table 7. Global Neurological Drugs Market Share in Value by Type (2018-2023)
Table 8. Global Neurological Drugs Price by Type (2018-2023) & (US$/Unit)
Table 9. Global Neurological Drugs Sales by Type (2024-2034) & (K Units)
Table 10. Global Neurological Drugs Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Neurological Drugs Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Neurological Drugs Sales Market Share in Value by Type (2024-2034)
Table 13. Global Neurological Drugs Price by Type (2024-2034) & (US$/Unit)
Table 14. North America Neurological Drugs Sales by Type (2018-2023) & (K Units)
Table 15. North America Neurological Drugs Sales by Type (2018-2023) & (US$ Million)
Table 16. Europe Neurological Drugs Sales (K Units) by Type (2018-2023)
Table 17. Europe Neurological Drugs Sales by Type (2018-2023) & (US$ Million)
Table 18. Asia-Pacific Neurological Drugs Sales (K Units) by Type (2018-2023)
Table 19. Asia-Pacific Neurological Drugs Sales by Type (2018-2023) & (US$ Million)
Table 20. Latin America Neurological Drugs Sales (K Units) by Type (2018-2023)
Table 21. Latin America Neurological Drugs Sales by Type (2018-2023) & (US$ Million)
Table 22. Middle East and Africa Neurological Drugs Sales (K Units) by Type (2018-2023)
Table 23. Middle East and Africa Neurological Drugs Sales by Type (2018-2023) & (US$ Million)
Table 24. Global Neurological Drugs Sales by Company (2018-2023) & (K Units)
Table 25. Global Neurological Drugs Sales Share by Company (2018-2023)
Table 26. Global Neurological Drugs Revenue by Company (2018-2023) & (US$ Million)
Table 27. Global Neurological Drugs Revenue Share by Company (2018-2023)
Table 28. Global Market Neurological Drugs Price by Company (2018-2023) & (US$/Unit)
Table 29. Global Neurological Drugs Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Neurological Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Neurological Drugs as of 2024)
Table 32. Date of Key Manufacturers Enter into Neurological Drugs Market
Table 33. Key Manufacturers Neurological Drugs Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Neurological Drugs Market Size Comparison by Region (US$ Million): 2018 VS 2024 VS 2034
Table 36. Global Neurological Drugs Sales by Region (2018-2023) & (K Units)
Table 37. Global Neurological Drugs Sales Market Share in Volume by Region (2018-2023)
Table 38. Global Neurological Drugs Sales by Region (2018-2023) & (US$ Million)
Table 39. Global Neurological Drugs Sales Market Share in Value by Region (2018-2023)
Table 40. Global Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 41. Global Neurological Drugs Sales by Region (2024-2034) & (K Units)
Table 42. Global Neurological Drugs Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Neurological Drugs Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Neurological Drugs Sales Market Share in Value by Region (2024-2034)
Table 45. Global Neurological Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2034)
Table 46. Global Neurological Drugs Sales by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 47. Global Neurological Drugs Sales by Application (2018-2023) & (K Units)
Table 48. Global Neurological Drugs Sales Market Share in Volume by Application (2018-2023)
Table 49. Global Neurological Drugs Sales by Application (2018-2023) & (US$ Million)
Table 50. Global Neurological Drugs Sales Market Share in Value by Application (2018-2023)
Table 51. Global Neurological Drugs Price by Application (2018-2023) & (US$/Unit)
Table 52. Global Neurological Drugs Sales by Application (2024-2034) & (K Units)
Table 53. Global Neurological Drugs Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Neurological Drugs Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Neurological Drugs Sales Market Share in Value by Application (2024-2034)
Table 56. Global Neurological Drugs Price by Application (2024-2034) & (US$/Unit)
Table 57. North America Neurological Drugs Sales by Application (2018-2023) (K Units)
Table 58. North America Neurological Drugs Sales by Application (2018-2023) & (US$ Million)
Table 59. Europe Neurological Drugs Sales by Application (2018-2023) (K Units)
Table 60. Europe Neurological Drugs Sales by Application (2018-2023) & (US$ Million)
Table 61. Asia-Pacific Neurological Drugs Sales by Application (2018-2023) (K Units)
Table 62. Asia-Pacific Neurological Drugs Sales by Application (2018-2023) & (US$ Million)
Table 63. Latin America Neurological Drugs Sales by Application (2018-2023) (K Units)
Table 64. Latin America Neurological Drugs Sales by Application (2018-2023) & (US$ Million)
Table 65. Middle East and Africa Neurological Drugs Sales by Application (2018-2023) (K Units)
Table 66. Middle East and Africa Neurological Drugs Sales by Application (2018-2023) & (US$ Million)
Table 67. North America Neurological Drugs Sales by Country (2018-2023) & (K Units)
Table 68. North America Neurological Drugs Sales Market Share in Volume by Country (2018-2023)
Table 69. North America Neurological Drugs Sales by Country (2018-2023) & (US$ Million)
Table 70. North America Neurological Drugs Sales Market Share in Value by Country (2018-2023)
Table 71. North America Neurological Drugs Sales by Country (2024-2034) & (K Units)
Table 72. North America Neurological Drugs Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Neurological Drugs Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Neurological Drugs Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Neurological Drugs Sales by Country (2018-2023) & (K Units)
Table 76. Europe Neurological Drugs Sales Market Share in Volume by Country (2018-2023)
Table 77. Europe Neurological Drugs Sales by Country (2018-2023) & (US$ Million)
Table 78. Europe Neurological Drugs Sales Market Share in Value by Country (2018-2023)
Table 79. Europe Neurological Drugs Sales by Country (2024-2034) & (K Units)
Table 80. Europe Neurological Drugs Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Neurological Drugs Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Neurological Drugs Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Neurological Drugs Sales by Region (2018-2023) & (K Units)
Table 84. Asia-Pacific Neurological Drugs Sales Market Share in Volume by Region (2018-2023)
Table 85. Asia-Pacific Neurological Drugs Sales by Region (2018-2023) & (US$ Million)
Table 86. Asia-Pacific Neurological Drugs Sales Market Share in Value by Region (2018-2023)
Table 87. Asia-Pacific Neurological Drugs Sales by Region (2024-2034) & (K Units)
Table 88. Asia-Pacific Neurological Drugs Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Neurological Drugs Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Neurological Drugs Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Neurological Drugs Sales by Country (2018-2023) & (K Units)
Table 92. Latin America Neurological Drugs Sales Market Share in Volume by Country (2018-2023)
Table 93. Latin America Neurological Drugs Sales by Country (2018-2023) & (US$ Million)
Table 94. Latin America Neurological Drugs Sales Market Share in Value by Country (2018-2023)
Table 95. Latin America Neurological Drugs Sales by Country (2024-2034) & (K Units)
Table 96. Latin America Neurological Drugs Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Neurological Drugs Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Neurological Drugs Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Neurological Drugs Sales by Country (2018-2023) & (K Units)
Table 100. Middle East and Africa Neurological Drugs Sales Market Share in Volume by Country (2018-2023)
Table 101. Middle East and Africa Neurological Drugs Sales by Country (2018-2023) & (US$ Million)
Table 102. Middle East and Africa Neurological Drugs Sales Market Share in Value by Country (2018-2023)
Table 103. Middle East and Africa Neurological Drugs Sales by Country (2024-2034) & (K Units)
Table 104. Middle East and Africa Neurological Drugs Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Neurological Drugs Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Neurological Drugs Sales Market Share in Value by Country (2024-2034)
Table 107. Pfizer Company Information
Table 108. Pfizer Introduction and Business Overview
Table 109. Pfizer Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Pfizer Neurological Drugs Product
Table 111. Pfizer Recent Development
Table 112. Ely Lilly Company Information
Table 113. Ely Lilly Introduction and Business Overview
Table 114. Ely Lilly Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Ely Lilly Neurological Drugs Product
Table 116. Ely Lilly Recent Development
Table 117. Actavis Company Information
Table 118. Actavis Introduction and Business Overview
Table 119. Actavis Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Actavis Neurological Drugs Product
Table 121. Actavis Recent Development
Table 122. Mylan Company Information
Table 123. Mylan Introduction and Business Overview
Table 124. Mylan Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Mylan Neurological Drugs Product
Table 126. Mylan Recent Development
Table 127. Randox Company Information
Table 128. Randox Introduction and Business Overview
Table 129. Randox Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. Randox Neurological Drugs Product
Table 131. Randox Recent Development
Table 132. Intellipharmaceutics Company Information
Table 133. Intellipharmaceutics Introduction and Business Overview
Table 134. Intellipharmaceutics Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 135. Intellipharmaceutics Neurological Drugs Product
Table 136. Intellipharmaceutics Recent Development
Table 137. Astrazeneca Company Information
Table 138. Astrazeneca Introduction and Business Overview
Table 139. Astrazeneca Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 140. Astrazeneca Neurological Drugs Product
Table 141. Astrazeneca Recent Development
Table 142. Lundbeck Company Information
Table 143. Lundbeck Introduction and Business Overview
Table 144. Lundbeck Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 145. Lundbeck Neurological Drugs Product
Table 146. Lundbeck Recent Development
Table 147. Allergan Company Information
Table 148. Allergan Introduction and Business Overview
Table 149. Allergan Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 150. Allergan Neurological Drugs Product
Table 151. Allergan Recent Development
Table 152. GSK Company Information
Table 153. GSK Introduction and Business Overview
Table 154. GSK Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 155. GSK Neurological Drugs Product
Table 156. GSK Recent Development
Table 157. Otsuka Pharmaceutical Company Information
Table 158. Otsuka Pharmaceutical Introduction and Business Overview
Table 159. Otsuka Pharmaceutical Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 160. Otsuka Pharmaceutical Neurological Drugs Product
Table 161. Otsuka Pharmaceutical Recent Development
Table 162. Takeda Company Information
Table 163. Takeda Introduction and Business Overview
Table 164. Takeda Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 165. Takeda Neurological Drugs Product
Table 166. Takeda Recent Development
Table 167. NHU Group Company Information
Table 168. NHU Group Introduction and Business Overview
Table 169. NHU Group Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 170. NHU Group Neurological Drugs Product
Table 171. NHU Group Recent Development
Table 172. Shionogi Company Information
Table 173. Shionogi Introduction and Business Overview
Table 174. Shionogi Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 175. Shionogi Neurological Drugs Product
Table 176. Shionogi Recent Development
Table 177. APOTEX Company Information
Table 178. APOTEX Introduction and Business Overview
Table 179. APOTEX Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 180. APOTEX Neurological Drugs Product
Table 181. APOTEX Recent Development
Table 182. North China Pharmaceutical Company Information
Table 183. North China Pharmaceutical Introduction and Business Overview
Table 184. North China Pharmaceutical Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 185. North China Pharmaceutical Neurological Drugs Product
Table 186. North China Pharmaceutical Recent Development
Table 187. Harbin Pharmaceutical Co., Ltd. Company Information
Table 188. Harbin Pharmaceutical Co., Ltd. Introduction and Business Overview
Table 189. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 190. Harbin Pharmaceutical Co., Ltd. Neurological Drugs Product
Table 191. Harbin Pharmaceutical Co., Ltd. Recent Development
Table 192. Lukang Pharmaceutical Company Information
Table 193. Lukang Pharmaceutical Introduction and Business Overview
Table 194. Lukang Pharmaceutical Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 195. Lukang Pharmaceutical Neurological Drugs Product
Table 196. Lukang Pharmaceutical Recent Development
Table 197. Kelun Pharmaceutical Company Information
Table 198. Kelun Pharmaceutical Introduction and Business Overview
Table 199. Kelun Pharmaceutical Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 200. Kelun Pharmaceutical Neurological Drugs Product
Table 201. Kelun Pharmaceutical Recent Development
Table 202. Kehua Biology Company Information
Table 203. Kehua Biology Introduction and Business Overview
Table 204. Kehua Biology Neurological Drugs Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2023)
Table 205. Kehua Biology Neurological Drugs Product
Table 206. Kehua Biology Recent Development
Table 207. Key Raw Materials Lists
Table 208. Raw Materials Key Suppliers Lists
Table 209. Neurological Drugs Market Trends
Table 210. Neurological Drugs Market Drivers
Table 211. Neurological Drugs Market Challenges
Table 212. Neurological Drugs Market Restraints
Table 213. Neurological Drugs Distributors List
Table 214. Neurological Drugs Downstream Customers
Table 215. Research Programs/Design for This Report
Table 216. Key Data Information from Secondary Sources
Table 217. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Drugs Product Picture
Figure 2. Global Neurological Drugs Market Size, 2018 VS 2024 VS 2034 (US$ Million)
Figure 3. Global Neurological Drugs Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Neurological Drugs Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of Non-prescription drugs
Figure 6. Global Non-prescription drugs Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Prescription
Figure 8. Global Prescription Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Global Neurological Drugs Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Neurological Drugs Sales Market Share by Type in 2024 & 2034
Figure 11. North America Neurological Drugs Sales Market Share in Volume by Type in 2024
Figure 12. North America Neurological Drugs Sales Market Share in Value by Type in 2024
Figure 13. Europe Neurological Drugs Sales Market Share in Volume by Type in 2024
Figure 14. Europe Neurological Drugs Sales Market Share in Value by Type in 2024
Figure 15. Asia-Pacific Neurological Drugs Sales Market Share in Volume by Type in 2024
Figure 16. Asia-Pacific Neurological Drugs Sales Market Share in Value by Type in 2024
Figure 17. Latin America Neurological Drugs Sales Market Share in Volume by Type in 2024
Figure 18. Latin America Neurological Drugs Sales Market Share in Value by Type in 2024
Figure 19. Middle East and Africa Neurological Drugs Sales Market Share in Volume by Type in 2024
Figure 20. Middle East and Africa Neurological Drugs Sales Market Share in Value by Type in 2024
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Neurological Drugs Sales in 2024
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Neurological Drugs Revenue in 2024
Figure 23. Neurological Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2024
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2034) & (K Units)
Figure 26. Product Picture of Clinic
Figure 27. Global Clinic Sales YoY Growth (2018-2034) & (K Units)
Figure 28. Global Neurological Drugs Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Neurological Drugs Sales Market Share by Application in 2024 & 2034
Figure 30. North America Neurological Drugs Sales Market Share in Volume by Application in 2024
Figure 31. North America Neurological Drugs Sales Market Share in Value by Application in 2024
Figure 32. Europe Neurological Drugs Sales Market Share in Volume by Application in 2024
Figure 33. Europe Neurological Drugs Sales Market Share in Value by Application in 2024
Figure 34. Asia-Pacific Neurological Drugs Sales Market Share in Volume by Application in 2024
Figure 35. Asia-Pacific Neurological Drugs Sales Market Share in Value by Application in 2024
Figure 36. Latin America Neurological Drugs Sales Market Share in Volume by Application in 2024
Figure 37. Latin America Neurological Drugs Sales Market Share in Value by Application in 2024
Figure 38. Middle East and Africa Neurological Drugs Sales Market Share in Value by Application in 2024
Figure 39. Key Raw Materials Price
Figure 40. Neurological Drugs Manufacturing Cost Structure
Figure 41. Neurological Drugs Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed